ROYSTON IVOR (CEO & President) sold 2.1% of their position (13.16K shares) of VIRACTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $25.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/27/2022ACC: 0001209191-22-032673
DirectorOfficer· CEO & President
Since Feb 2021
-13.16K
Net shares
Net seller
$25.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25.22K acquired · 38.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.22K
Price / share
—
Trade value
—
% of position
4.3%
5/25/2022
588.87K→614.09K
Common Stock
Direct
Shares
−13.16K
Price / share
$1.90
Trade value
$25.02K
% of position
2.1%
5/26/2022
614.09K→600.93K
Total
Net shares
+12.06K
Net value
-$25.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2022 | M · Option Exercise | +25.22K | — | — | 4.3% | 588.87K | 614.09K |
| Common Stock Direct | 5/26/2022 | S · Sale | −13.16K | $1.90 | $25.02K | 2.1% | 614.09K | 600.93K |
| Total | +12.06K | -$25.02K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
25.22K shares
Shares
−25.22K
Strike price
Held after
302.63K
Exercisable
—
5/25/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25.22K shares | 5/25/2022 | M · Option Exercise | −25.22K | — | 302.63K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned18.60K
Total
18.60K indirect18.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.60K | Indirect |
| Total | 18.60K | 18.60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported